Get the Stockscreener App
8.49
3.79%
0.31
Cvrx Inc stock is traded at $8.49, with a volume of 188.47K.
It is up +3.79% in the last 24 hours and up +26.34% over the past month.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
See More
Previous Close:
$8.18
Open:
$8.18
24h Volume:
188.47K
Relative Volume:
0.58
Market Cap:
$223.39M
Revenue:
$47.26M
Net Income/Loss:
$-58.48M
P/E Ratio:
-3.1387
EPS:
-2.7049
Net Cash Flow:
$-40.45M
1W Performance:
+10.98%
1M Performance:
+26.34%
6M Performance:
+10.26%
1Y Performance:
-29.78%
1-Day Range:
$8.0039
$8.69
1-Week Range:
$7.34
$8.69
52-Week Range:
$4.2993
$13.34
Cvrx Inc Stock (CVRX) Company Profile
Name
Cvrx Inc
Sector
Industry
Phone
(763) 416-2850
Address
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Compare CVRX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
8.49 | 215.23M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-09-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-14-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Sep-10-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-11-24 | Reiterated | Lake Street | Buy |
| May-01-24 | Resumed | Craig Hallum | Buy |
| May-01-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-01-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-31-23 | Initiated | Lake Street | Buy |
| Jul-18-22 | Initiated | Craig Hallum | Buy |
| Jul-26-21 | Initiated | Canaccord Genuity | Buy |
| Jul-26-21 | Initiated | Piper Sandler | Overweight |
| Jul-26-21 | Initiated | William Blair | Outperform |
View All
Cvrx Inc Stock (CVRX) Latest News
CVRx Introduces New Performance-Based Executive Stock Unit Plan - The Globe and Mail
CVRx (CVRX) lists Chief HR Officer Gregory Morrison as insider on Form 3 - Stock Titan
CVRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CVRx (NASDAQ: CVRX) CFO gets major option, RSU grants and tax sale - Stock Titan
CVRx (CVRX) CEO Kevin Hykes gets major equity grants, sells shares for taxes - Stock Titan
CVRx (NASDAQ: CVRX) officer receives major equity grants, sells shares to cover taxes - Stock Titan
CVRx (NASDAQ: CVRX) CRO gets new stock awards, sells shares for taxes - Stock Titan
COO of CVRx (NASDAQ: CVRX) receives 23,000 options and 15,000 shares - Stock Titan
CVRx approves performance stock units tied to 2026-2027 revenue goals - Investing.com
CVRx (NASDAQ: CVRX) grants revenue-linked PSUs to executives - Stock Titan
CVRX,INVA Dividends - Finviz
SGP,CVRX Earnings - Finviz
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
CVRx opens THT2026 with new scientific data on Barostim outcomes - Traders Union
Heart failure device Barostim tested in 400 patients, data due at THT 2026 - Stock Titan
SGP,CVRX Short Interest - Finviz
CVRX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CVRx partners with Orlando Health South Lake Hospital for first Barostim implant - Traders Union
IMA,CVRX Dividends - Finviz
CVRx unveils new Barostim research at THT2026 satellite program - Traders Union
IMA,CVRX Latest SEC Filings - Finviz
Smart Money: Should you buy the dip on CVRx IncJuly 2025 Momentum & Low Volatility Stock Suggestions - baoquankhu1.vn
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc.CVRX - Bluefield Daily Telegraph
CVRx celebrates milestone with 101st Barostim implant - Traders Union
Market Catalysts: What is the earnings history of CVRx IncWeekly Market Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
(CVRX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
$CVRX stock is up 9% today. Here's what we see in our data. - Quiver Quantitative
Monday 2/23 Insider Buying Report: MPLT, CVRX - Nasdaq
Craig-Hallum Maintains CVRx Inc(CVRX.US) With Buy Rating - 富途牛牛
CVRx (NASDAQ:CVRX) Director Buys $297,648.00 in Stock - MarketBeat
CVRx director Jain Mudit K. buys $297k in shares By Investing.com - Investing.com India
CVRx director Jain Mudit K. buys $297k in shares - Investing.com Australia
Insider Purchase: Director at $CVRX Buys 46,800 Shares - Quiver Quantitative
CVRx : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
Director-linked Treo Ventures buys 46,800 CVRx (CVRX) shares - Stock Titan
Bank Watch: Is CVRX stock heavily shorted2025 Macro Impact & Weekly Return Optimization Plans - baoquankhu1.vn
Earnings call transcript: CVRx Q4 2025 sees stock surge despite earnings miss - Investing.com Nigeria
CVRx hosts Advanced Practice Providers Summit in Nashville - Traders Union
Landmark Heart Failure Trial Begins - Medical Product Outsourcing
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz - The AI Journal
CVRx, Inc. (CVRX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - marketscreener.com
Can CVRx Inc keep up with sector leadersJuly 2025 Closing Moves & Fast Exit Strategy with Risk Control - baoquankhu1.vn
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - marketscreener.com
CVRx (NASDAQ:CVRX) Stock Rating Upgraded by Cantor Fitzgerald - Defense World
Cantor Fitzgerald Upgrades CVRx (NASDAQ:CVRX) to Strong-Buy - MarketBeat
Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc.CVRX - marketscreener.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beta Bionics, Inc. - GlobeNewswire Inc.
Short Interest in CVRx, Inc. (NASDAQ:CVRX) Increases By 23.4% - MarketBeat
Why CVRx Inc. stock remains on buy listsAnalyst Downgrade & Long Hold Capital Preservation Plans - mfd.ru
CVRx Inc (CVRX) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions Amid ... By GuruFocus - Investing.com Canada
Analysts Are Updating Their CVRx, Inc. (NASDAQ:CVRX) Estimates After Its Full-Year Results - Yahoo Finance
Cvrx Inc Stock (CVRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):